Literature DB >> 25345997

Subthalamic nucleus deep brain stimulation for Parkinson's disease: evidence for effectiveness and limitations from 12 years' experience.

Anne Y Y Chan1, Jonas H M Yeung2, Vincent C T Mok1, Vincent H L Ip1, Adrian Wong1, S H Kuo3, Danny T M Chan4, X L Zhu4, Edith Wong4, Claire K Y Lau4, Rosanna K M Wong5, Venus Tang6, Christine Lau1, W S Poon4.   

Abstract

OBJECTIVE: To present the result and experience of subthalamic nucleus deep brain stimulation for Parkinson's disease.
DESIGN: Case series.
SETTING: Prince of Wales Hospital, Hong Kong. PATIENTS: A cohort of patients with Parkinson's disease received subthalamic nucleus deep brain stimulation from September 1998 to January 2010. Patient assessment data before and after the operation were collected prospectively.
RESULTS: Forty-one patients (21 male and 20 female) with Parkinson's disease underwent bilateral subthalamic nucleus deep brain stimulation and were followed up for a median interval of 12 months. For the whole group, the mean improvements of Unified Parkinson's Disease Rating Scale (UPDRS) parts II and III were 32.5% and 31.5%, respectively (P<0.001). Throughout the years, a multidisciplinary team was gradually built. The deep brain stimulation protocol evolved and was substantiated by updated patient selection criteria and outcome assessment, integrated imaging and neurophysiological targeting, refinement of surgical technique as well as the accumulation of experience in deep brain stimulation programming. Most of the structural improvement occurred before mid-2005. Patients receiving the operation before June 2005 (19 cases) and after (22 cases) were compared; the improvements in UPDRS part III were 13.2% and 55.2%, respectively (P<0.001). There were three operative complications (one lead migration, one cerebral haematoma, and one infection) in the group operated on before 2005. There was no operative mortality.
CONCLUSIONS: The functional state of Parkinson's disease patients with motor disabilities refractory to best medical treatment improved significantly after subthalamic nucleus deep brain stimulation. A dedicated multidisciplinary team building, refined protocol for patient selection and assessment, improvement of targeting methods, meticulous surgical technique, and experience in programming are the key factors contributing to the improved outcome.

Entities:  

Keywords:  Deep brain stimulation; Parkinson disease; Subthalamic nucleus

Mesh:

Year:  2014        PMID: 25345997      PMCID: PMC4691215          DOI: 10.12809/hkmj144242

Source DB:  PubMed          Journal:  Hong Kong Med J        ISSN: 1024-2708            Impact factor:   2.227


  9 in total

1.  Stimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow up.

Authors:  W M M Schüpbach; N Chastan; M L Welter; J L Houeto; V Mesnage; A M Bonnet; V Czernecki; D Maltête; A Hartmann; L Mallet; B Pidoux; D Dormont; S Navarro; P Cornu; A Mallet; Y Agid
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-12       Impact factor: 10.154

Review 2.  Surgical management of Parkinson's disease: a critical review.

Authors:  D T Chan; V C Mok; W S Poon; K N Hung; X L Zhu
Journal:  Hong Kong Med J       Date:  2001-03       Impact factor: 2.227

3.  Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease.

Authors:  Elena Moro; Andres M Lozano; Pierre Pollak; Yves Agid; Stig Rehncrona; Jens Volkmann; Jaime Kulisevsky; Jose A Obeso; Alberto Albanese; Marwan I Hariz; Niall P Quinn; Jans D Speelman; Alim L Benabid; Valerie Fraix; Alexandre Mendes; Marie-Laure Welter; Jean-Luc Houeto; Philippe Cornu; Didier Dormont; Annalena L Tornqvist; Ron Ekberg; Alfons Schnitzler; Lars Timmermann; Lars Wojtecki; Andres Gironell; Maria C Rodriguez-Oroz; Jorge Guridi; Anna R Bentivoglio; Maria F Contarino; Luigi Romito; Massimo Scerrati; Marc Janssens; Anthony E Lang
Journal:  Mov Disord       Date:  2010-04-15       Impact factor: 10.338

4.  Comparison of weight gain and energy intake after subthalamic versus pallidal stimulation in Parkinson's disease.

Authors:  Paul Sauleau; Emmanuelle Leray; Tiphaine Rouaud; Sophie Drapier; Dominique Drapier; Sophie Blanchard; Gwenolla Drillet; Julie Péron; Marc Vérin
Journal:  Mov Disord       Date:  2009-10-30       Impact factor: 10.338

Review 5.  Complications of deep brain stimulation: a collective review.

Authors:  Danny T M Chan; Xian Lun Zhu; Jonas H M Yeung; Vincent C T Mok; Edith Wong; Clara Lau; Rosanna Wong; Christine Lau; Wai S Poon
Journal:  Asian J Surg       Date:  2009-10       Impact factor: 2.767

6.  Mechanisms of body weight gain in patients with Parkinson's disease after subthalamic stimulation.

Authors:  C Montaurier; B Morio; S Bannier; P Derost; P Arnaud; M Brandolini-Bunlon; C Giraudet; Y Boirie; F Durif
Journal:  Brain       Date:  2007-05-29       Impact factor: 13.501

7.  Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease.

Authors:  Paul Krack; Alina Batir; Nadège Van Blercom; Stephan Chabardes; Valérie Fraix; Claire Ardouin; Adnan Koudsie; Patricia Dowsey Limousin; Abdelhamid Benazzouz; Jean François LeBas; Alim-Louis Benabid; Pierre Pollak
Journal:  N Engl J Med       Date:  2003-11-13       Impact factor: 91.245

Review 8.  A noninvasive imaging approach to understanding speech changes following deep brain stimulation in Parkinson's disease.

Authors:  Shalini Narayana; Adam Jacks; Donald A Robin; Howard Poizner; Wei Zhang; Crystal Franklin; Mario Liotti; Deanie Vogel; Peter T Fox
Journal:  Am J Speech Lang Pathol       Date:  2008-11-24       Impact factor: 2.408

9.  Deep brain stimulation hardware complications in patients with movement disorders: risk factors and clinical correlations.

Authors:  José Fidel Baizabal Carvallo; Giovanni Mostile; Mike Almaguer; Anthony Davidson; Richard Simpson; Joseph Jankovic
Journal:  Stereotact Funct Neurosurg       Date:  2012-07-12       Impact factor: 1.875

  9 in total
  3 in total

1.  Deep Brain Electrode Externalization and Risk of Infection: A Systematic Review and Meta-Analysis.

Authors:  Alon Kashanian; Pratik Rohatgi; Srinivas Chivukula; Sameer A Sheth; Nader Pouratian
Journal:  Oper Neurosurg (Hagerstown)       Date:  2021-01-13       Impact factor: 2.703

Review 2.  p38 MAPK and PI3K/AKT Signalling Cascades inParkinson's Disease.

Authors:  Saurabh Kumar Jha; Niraj Kumar Jha; Rohan Kar; Rashmi K Ambasta; Pravir Kumar
Journal:  Int J Mol Cell Med       Date:  2015

3.  Deep Brain Stimulation in Moroccan Patients With Parkinson's Disease: The Experience of Neurology Department of Rabat.

Authors:  Mounia Rahmani; Maria Benabdeljlil; Fouad Bellakhdar; Mustapha El Alaoui Faris; Mohamed Jiddane; Khalil El Bayad; Fatima Boutbib; Rachid Razine; Rachid Gana; Moulay R El Hassani; Nizar El Fatemi; Meryem Fikri; Siham Sanhaji; Hennou Tassine; Imane El Alaoui Balrhiti; Souad El Hadri; Najwa Ech-Cherif Kettani; Najia El Abbadi; Mourad Amor; Abdelmjid Moussaoui; Afifa Semlali; Saadia Aidi; El Hachmia Ait Benhaddou; Ali Benomar; Ahmed Bouhouche; Mohamed Yahyaoui; Abdeslam El Khamlichi; Abdessamad El Ouahabi; Rachid El Maaqili; Houyam Tibar; Yasser Arkha; Adyl Melhaoui; Abdelhamid Benazzouz; Wafa Regragui
Journal:  Front Neurol       Date:  2018-07-31       Impact factor: 4.003

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.